Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications

被引:91
作者
Grassi, Guido [1 ,2 ]
Seravalle, Gino [3 ]
Mancia, Giuseppe [1 ,3 ]
机构
[1] Univ Milano Bicocca, Dipartimento Sci Salute, Med Clin, I-20052 Milan, Italy
[2] Sesto San Giovanni, IRCCS Multimed, Milan, Italy
[3] Ist Auxol Italiano, Milan, Italy
关键词
Congestive heart failure; drug treatment; hypertension; myocardial infarction; prognosis; sympathetic nervous system; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; HEART-FAILURE; PLASMA NOREPINEPHRINE; BAROREFLEX FUNCTION; RENAL DENERVATION; SENSITIVITY; MOXONIDINE; MORTALITY; RESPONSES;
D O I
10.1111/eci.12553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The sympathetic nervous exerts a key role in cardiovascular homeostasis control by regulating cardiac output, systemic vascular resistance, heart rate and blood pressure. Materials and methods Data collected during the past 30 years have unequivocally shown that in a considerable number of cardiovascular as well as noncardiovascular disease there is a marked activation of the sympathetic nervous system which exerts in the long-term period unfavourable haemodynamic, metabolic, cardiovascular and renal effects. Results This paper will review the current knowledge on the alterations in sympathetic function described in cardiovascular disease, with particular focus on hypertension, heart failure and myocardial infarction. Conclusions The consequences of the phoenomenon will be discussed together with its therapeutic implications. This will be done by examining the impact of nonpharmacological as well as pharmacological interventions on sympathetic cardiovascular drive. The effects of new invasive approaches, such as carotid baroreceptor stimulation as well as renal nerves ablation, will be also briefly discussed.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 43 条
  • [31] Chemoreflexes, Sleep Apnea, and Sympathetic Dysregulation
    Mansukhani, Meghna P.
    Kara, Tomas
    Caples, Sean M.
    Somers, Virend K.
    [J]. CURRENT HYPERTENSION REPORTS, 2014, 16 (09) : 1 - 12
  • [32] MCDONALD L, 1969, LANCET, V2, P1021
  • [33] Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure
    Neumann, J
    Ligtenberg, G
    Oey, L
    Koomans, HA
    Blankestijn, PJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11): : 2902 - 2907
  • [34] OSTERZIEL KJ, 1995, BRIT HEART J, V73, P517
  • [35] Quarti F, 2010, HIGH BLOOD PRESS, V17, P180
  • [36] Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke
    Sander, D
    Winbeck, K
    Klingelhöfer, J
    Etgen, T
    Conrad, B
    [J]. NEUROLOGY, 2001, 57 (05) : 833 - 838
  • [37] Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states
    Seravalle, Gino
    Lonati, Laura
    Buzzi, Silvia
    Cairo, Matteo
    Trevano, Fosca Quarti
    Dell'Oro, Raffaella
    Facchetti, Rita
    Mancia, Giuseppe
    Grassi, Guido
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 (07) : 1411 - 1417
  • [38] Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias
    Shen, Mark J.
    Zipes, Douglas P.
    [J]. CIRCULATION RESEARCH, 2014, 114 (06) : 1004 - 1021
  • [39] Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P399, DOI 10.1111/j.1524-6175.2007.07161.x
  • [40] PLASMA NOREPINEPHRINE IN CONGESTIVE HEART-FAILURE
    THOMAS, JA
    MARKS, BH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) : 233 - 243